Amlodipine Besylate is one of 56 small molecule programs targeting Liver Transplant. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
566 competitors in Hypertension
Amlodipine Besylate
Apresoline
Zebeta
Edarbi
Winrevair
Alphagan
Deltavit
Avastin
Ultiva
Vivarin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details